drugset / Trial / NCT00249223
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of the study is to show that treatment with an injectable formulation of risperidone is not less effective than and has a similar safety profile to risperidone tablets in patients with chronic schizophrenia.
Timeline
- Start
- 2000-01
- Primary completion
- —
- Completion
- 2000-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 25 mg | — |
| Subject | Risperidone | Other / unclassified | 50 mg | — |
| Subject | Risperidone | Other / unclassified | 75 mg | — |